Endosense nets $36M in financing for catheter ablation technology

Justine Varieur Cadet | | Cardiovascular Business | Heart Rhythm
Endosense, a medical technology company focused on catheter ablation to treat cardiac arrhythmias, has received $36 million in series B financing.

Edmond de Rothschild Investment Partners led the round, with additional participation from Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

The Geneva-based company said the financing will primarily be used to fund the European commercialization and U.S. premarket approval clinical study of the company’s force-sensing ablation catheter, the TactiCath, which was granted the CE Mark in May.

As part of the series B activity, Endosense said it has made several board appointments to reflect its new shareholder mix. Edmond de Rothschild’s Partner Olivier Litzka, Gimv’s Executive Vice President of Life Sciences Patrick van Beneden and VI Partner’s Diego Braguglia have become directors.

Justine Varieur Cadet

Related Content

FDA approves new short-term treatment for AFib, atrial flutter in critical care settings
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."